Patients With Multiple Sclerosis Treated With TYSABRI Show Overall Improvement In Cognition And Quality Of Life, With Lower Levels Of Fatigue

Links shared publicly online about this topic.

  • 2,076
    total visits

Patients With Multiple Sclerosis Treated With TYSABRI Show Overall Improvement In Cognition And Quality Of Life, With Lower Levels Of Fatigue

medicalnewstoday.com —

Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) have announced results from an ongoing, one-year longitudinal health outcomes study (n=1275) in which patients who received three i

View full resource at medicalnewstoday.com

Tags: Multiple Sclerosis, Tysabri, Biogen Idec, Elan Corp.

  • Share

Most Recently Shared on May 1, 2009 at 11:59 am By:

LisaEmrich Lisa Emrich

MedNewsToday: Patients With Multiple Sclerosis Treated With TYSABRI Show Overall Improvement In Cog.. http://tinyurl.com/db63mg

3 years ago...

Reply

Retweet

Favorite

Also Shared By:

psychiatryrounds psychiatryrounds

Advertisement